Journal of Antibiotics 1996-01-01

A-72363 A-1, A-2 and C, novel heparanase inhibitors from Streptomyces nobilis SANK 60192. I. Taxonomy of producing organism, fermentation, isolation and structure elucidation.

T Takatsu, M Takahashi, Y Kawase, R Enokita, T Okazaki, H Matsukawa, K Ogawa, Y Sakaida, T Kagasaki, T Kinoshita, M Nakajima, K Tanzawa

Index: J. Antibiot. 49(1) , 54-60, (1996)

Full Text: HTML

Abstract

Novel heparanse inhibitors, A72363 A-1, A-2, and C, were isolated from the culture filtrate of Streptomyces nobilis SANK 60192 by column chromatography on various resinous adsorbents, followed by preparative anion exchange HPLC. Spectroscopic studies revealed that they are diastereomers of siastatin B, a neuraminidase inhibitor.


Related Compounds

Related Articles:

Contributions of NanI sialidase to Caco-2 cell adherence by Clostridium perfringens type A and C strains causing human intestinal disease.

2014-11-01

[Infect. Immun. 82(11) , 4620-30, (2014)]

Syntheses and activities of N-substituted derivatives of siastatin B.

1992-10-01

[J. Antibiot. 45(10) , 1662-8, (1992)]

Synthesis of 3-episiastatin B analogues having anti-influenza virus activity.

1993-12-01

[J. Antibiot. 46(12) , 1883-9, (1993)]

Synthesis of the sialidase inhibitor siastatin B.

2007-05-01

[Org. Lett. 2 , 4037, (2000)]

A-72363 A-1, A-2, and C, novel heparanase inhibitors from Streptomyces nobilis SANK 60192, II. Biological activities.

1996-01-01

[J. Antibiot. 49(1) , 61-4, (1996)]

More Articles...